- Forums
- ASX - By Stock
- RAC
- Ann: Zantrene highly effective in Melanoma preclinical study
Ann: Zantrene highly effective in Melanoma preclinical study, page-4
-
- There are more pages in this discussion • 176 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.74 |
Change
0.035(2.06%) |
Mkt cap ! $289.5M |
Open | High | Low | Value | Volume |
$1.74 | $1.75 | $1.73 | $46.89K | 26.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 5720 | $1.73 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.75 | 3 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 650 | 1.730 |
1 | 1100 | 1.725 |
2 | 2600 | 1.720 |
1 | 1100 | 1.715 |
2 | 1832 | 1.710 |
Price($) | Vol. | No. |
---|---|---|
1.745 | 3 | 1 |
1.750 | 200 | 1 |
1.765 | 750 | 1 |
1.770 | 416 | 1 |
1.780 | 410 | 1 |
Last trade - 10.35am 08/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |